Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences QbD in Pharma Development World Congress 2017

QbD in Pharma Development World Congress 2017

Date: Thursday, 20 April 2017 - Friday, 21 April 2017
Location: Hyderabad

Guest of Honour

P B N Prasad

P B N Prasad
Deputy Drugs Controller (India), Central Drugs Standard Control Organization

Keynote Speakers

Bhupinder Singh Bhoop

Bhupinder Singh Bhoop
Dean, UIPS, Panjab University


We are delighted to announce our 4th International conference “QbD in Pharma Development World Congress 2017” with the theme "Emerging Challenges, Federal Issues & Possible Solutions" scheduled to be held on April 20-21, 2017 in Hyderabad, India. This year the event has been planned so as to bring together the experts from across the globe making it a mega event.

The federal agencies have reiterated to build quality into the products during multi-phase product development life cycle and eventually, enhance product and/or process understanding, all using the rational and systematic QbD. The key elements of QbD, including the QTPP, CQAs, QRM, CMA, CPP and control strategy, as enumerated in the ICH guidelines viz. Q8, Q9, Q10 and Q11, are being followed and QbD paradigms implemented in several pharmaceutical companies. 

Nevertheless, much water has flown in the Ganges and Amazon since the proclamation of QbD guidance by the ICH, and subsequent endorsement by US FDA, EMEA, EGA, MHRA and so on. The acute need of the hour today is to address these issues, meet these challenges and provide custom tailored solutions to the problems which the scientists in pharmaceutical industry are currently facing during QbD implementation. Rather than dealing with scattered thoughts, this conference would endeavour to provide a comprehensive one-stop platform to deal with the disparate vistas catering to the scientists in industry and research.

The event will feature experts who are adept in this science and risk-based approaches, and therefore, will offer definitive benefits to the scientists from academia and industry working in the domains of Product Development, Process R & D, Scale-up, Manufacturing, Quality Assurance, Global Regulatory Affairs, API, Excipients, Pharmaceutical Analysis and Technology Transfer. The speakers will articulate on all the pertinent areas of QbD Implementation including Manufacturing, Formulation, Analytical Development and Excipients. 

The event will be co-located with our International conference "Novel Formulation Strategies" in Hyderabad, India. Registered delegates will have unrestricted access to all the co-located meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.

Register NOW. For details, please contact Ms Farheen Zainab ( M: 7696125050

Venue and Dates: Hotel Radisson Hyderabad, Hitec City, Hyderabad, India on April 20-21, 2017

Sponsorship Options: Pharmaceutical Industry willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.

Agenda Topics

  • Analytical QbD
  • Design of Experiments
  • Design Strategies for Dissolutions, Bioequivalence & Stability
  • Federal Perspectives & Issues
  • Formulation by Design
  • Multivariate Chemometric Tools
  • PAT and RTRT tools
  • QbD and QbR
  • QbD in API Manufacturing Process
  • QbD in Product Life Cycle
  • QbD Perspectives in Biologicals
  • Quality Culture in Product Development
  • Risk Estimation Monitoring

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager

Confirmed Speakers to date

Quaisar Anwar, Assistant Vice President, Recipharm Pharmaservices Pvt. Ltd
Mrunal Jaywant, Senior Director, USP India Private Limited
Dhileep Krishnamurthy, CSO, Zhejiang NHU Company Ltd
Suresh Kumar, Team Lead, Novartis
Shib Mookherjea, Senior Director, ValQual International
Asha Patel, Associate Professor, Parul University
Devendra Ridhurkar, Senior Scientist, Egis Pharmaceuticals
Gautam Samanta, Vice President - Quality by Design and Process Scale-up, Cipla Ltd
Nalini Shastri, Associate Professor, National Institute of Pharmaceutical Education and Research
Satish Singh, Head, Lonza Inc
Neerja Somyajee, Manager, Anacipher Clinical Research
Korupoju Srinivasa Rao, Director-QbD PharmaSolutions, Piramal Enterprises Limited
Sushil Srivastava, Process Research and Development Director, Bristol-Myers Squibb

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2017-04-20 00:00:002017-04-21 00:00:00Europe/LondonQbD in Pharma Development World Congress 2017QbD in Pharma Development World Congress 2017 in